Skip to content

Clinical trials

Phase 3 Non-alcoholic Fatty Liver Disease trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Phase: Phase 3 Country / region: Belgium Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20151
20161
20173
20191
20212
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated6
Active, not recruiting3
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
89bio, Inc.2
Gilead Sciences2
Eli Lilly and Company1
Genfit1
GlaxoSmithKline1
Intercept Pharmaceuticals1
Inventiva Pharma1
Madrigal Pharmaceuticals, Inc.1
Novo Nordisk A/S1
Tobira Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease12
Fibrosis4
Liver Diseases4
Fatty Liver3
Digestive System Diseases2
Metabolic Diseases2
Acquired Immunodeficiency Syndrome1
HIV Infections1
Hepatitis B1
Hepatitis C1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.